A new vaccine has shown promise at treating a presently incurable type of brain cancer in a groundbreaking clinical trial.
The vaccine was tested on four adult patients with glioblastoma, the most common and deadly type of brain tumour. It was found to provoke a “fierce” immune response, training the body to recognise cancer cells as harmful and attack the brain tumour so it could no longer grow unchecked.
Personalised cancer vaccines are a new and exciting field of medicine and experts hope they will revolutionise treatment options. They are a type of immunotherapy, made using the same mRNA technology seen in Covid vaccines, and recent trials have shown that they can improve survival rates in skin cancer and pancreatic cancer.
The new study, led
